secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2025-10-31T23:59:59+00:00
Accession:  0001640334-25-001930
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences issues $690K convertible notes and warrants to investors including directors
--------------------------------------------------------------------------------

- Issued convertible notes aggregating $690,154.69 principal to investors, converting May 2025 notes.
- Notes bear 12% interest (20% on default), mature ~April 28, 2026, convertible at $3.40/share.
- Warrants to purchase 438,182 shares of common stock at $3.40 per share, exercisable for 5 years.
- Directors Connie Matsui ($110,842), Tamara Favorito ($19,793), and CEO Gregory Gorgas ($27,710) participated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425001930/0001640334-25-001930-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425001930/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-001930

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer